Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
At Quest Diagnostics, Inc. (NYSE:DGX), a filing with the SEC revealed that on Tuesday, CEO Stephen H. Rusckowski bought 20,000 shares of DGX, at a cost of $56.89 each, for a total investment of $1.14M. Rusckowski was up about 2.2% on the purchase at the high point of today's trading session, with DGX trading as high as $58.15 in trading on Thursday. Quest Diagnostics, Inc. is trading up about 1.3% on the day Thursday.
And on Monday, CFO Andrew B. Szafran purchased $745,000 worth of Tellabs, Inc. (NASDAQ:TLAB), purchasing 200,000 shares at a cost of $3.73 a piece. This buy marks the first one filed by Szafran in the past twelve months. Tellabs, Inc. is trading down about 0.3% on the day Thursday. So far Szafran is in the green, up about 4.4% on their purchase based on today's trading high of $3.89.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.